You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sargramostim

Showing 1 - 25 of 536
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Solid Tumor, Adult Trial (Sargramostim, Ipilimumab-containing therapy)

Suspended
  • Solid Tumor
  • Solid Tumor, Adult
  • Sargramostim
  • Ipilimumab-containing therapy
  • Lexington, Massachusetts
    Partner Therapeutics - No Currently Active Sites
Nov 30, 2022

Parkinson's Disease and Parkinsonism Trial in Omaha (Sargramostim)

Not yet recruiting
  • Parkinson's Disease and Parkinsonism
  • Sargramostim
  • Omaha, Nebraska
    University of Nebraska Medical Center
Dec 22, 2022

Drug Kinetics, Drug Effects on Physiology Trial in Mount-Royal (sargramostim)

Completed
  • Drug Kinetics
  • Drug Effects on Physiology
  • sargramostim
  • Mount-Royal, Quebec, Canada
    AltaSciences
Sep 30, 2022

Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab

Recruiting
  • Unresectable Melanoma
  • +3 more
  • Sargramostim (GM-CSF)
  • Pembrolizumab (anti-PD-1)
  • Boston, Massachusetts
  • +1 more
Jul 6, 2022

Down Syndrome Trial in Aurora (Sargramostim for Injection, Saline Placebo)

Not yet recruiting
  • Down Syndrome
  • Sargramostim for Injection
  • Saline Placebo
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Jul 28, 2022

Alzheimer Trial in Aurora (Sargramostim, Saline - comparator)

Recruiting
  • Alzheimer Disease
  • Sargramostim
  • Saline - placebo comparator
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Jul 19, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Lung, Metastatic Melanoma Trial in Rochester

Not yet recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +4 more
  • Aerosol Sargramostim
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 23, 2022

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)

Completed
  • Chronic Myeloproliferative Disorders
  • +5 more
  • sargramostim
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 3, 2022

Parkinson Disease Trial in Omaha (sargramostim)

Active, not recruiting
  • Parkinson Disease
  • sargramostim
  • Omaha, Nebraska
    University of Nebraska Medical Center
Oct 19, 2022

Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)

Recruiting
  • Transplant-Related Hematologic Malignancy
  • Sargramostim
  • Control Arm
  • Atlanta, Georgia
    Northside Hospital
Oct 19, 2022

Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle

Active, not recruiting
  • HER2-positive Breast Cancer
  • +8 more
  • pNGVL3-hICD vaccine
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022

Transitional Cell Carcinoma Trial in New York (TICE®-strain BCG, NY-ESO-1 protein, sargramostim)

Completed
Has Results
  • Transitional Cell Carcinoma
  • TICE®-strain BCG
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

COVID-19, SARS-CoV-2 Trial in United States (Sargramostim, Standard of care)

Completed
Has Results
  • COVID-19
  • SARS-CoV-2
  • Sargramostim
  • Standard of care
  • Fullerton, California
  • +10 more
Feb 16, 2022

COVID-19 Trial in Japan (Sargramostim, Placebo)

Completed
  • COVID-19
  • Sargramostim
  • Placebo
  • Narita City, Chiba, Japan
  • +6 more
Nov 1, 2021

Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

Recruiting
  • Neuroblastoma Recurrent
  • Natural killer cell
  • +4 more
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Feb 22, 2023

Diffuse, Large B-Cell, Lymphoma Trial in Los Angeles (Rituximab)

Completed
  • Diffuse, Large B-Cell, Lymphoma
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Nov 15, 2021

Autoimmune Pulmonary Alveolar Proteinosis Trial in Los Altos, Cincinnati (Sargramostim)

Completed
  • Autoimmune Pulmonary Alveolar Proteinosis
  • Sargramostim
  • Los Altos, California
  • +1 more
Aug 2, 2021

Mantle Cell Lymphoma, Lymphoma, Mantle Cell Trial run by the NCI (EPOCH-R, GM-CSF, Idiotype vaccine)

Completed
Has Results
  • Mantle Cell Lymphoma
  • Lymphoma, Mantle Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 4, 2023

Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Aurora (cryotherapy, sargramostim)

Completed
  • Recurrent Prostate Cancer
  • +3 more
  • cryotherapy
  • sargramostim
  • Aurora, Colorado
    University of Colorado Cancer Center
Feb 8, 2022

Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)

Terminated
  • Neuroblastoma
  • antibody ch14.18
  • +4 more
  • Cologne, Germany
    University of Cologne
Nov 3, 2022

Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)

Recruiting
  • Relapsed Neuroblastoma
  • Refractory Neuroblastoma
  • Natural Killer Cells
  • +4 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 26, 2022

Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)

Not yet recruiting
  • Advanced Ovarian Cancer
  • AST-201
  • +4 more
  • Seattle, Washington
    University of Washington
Mar 20, 2023

Partial Response of Multiple Myeloma or Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Buffalo, Rochester (biological,

Active, not recruiting
  • Partial Response of Multiple Myeloma or Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Incomplete Freund's Adjuvant
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 12, 2022